CorCap gets another shot
This article was originally published in The Gray Sheet
Executive Summary
FDA will reconsider approval of Acorn Cardiovascular's CorCap mesh wrap treatment for heart failure following completion of a 50-patient confirmatory trial, the firm announces May 9. In December, FDA's Medical Device Dispute Resolution Panel supported the agency's decision not to approve the cardiac support device, based on the firm's 2004 submission of a 300-patient randomized trial (1"The Gray Sheet" Jan. 1, 2007, p. 14). Acorn says it plans to begin the new study, which will have six-month follow-up, this summer, potentially leading to CorCap approval in late 2008 or early 2009. Completion of the trial will require Acorn to "immediately" raise $15 million, the firm says...